| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CASTLE BIOSCIENCES INC | Director | Common Stock | 22K | $442K | $20.11 | May 21, 2025 | Direct |
| Kiniksa Pharmaceuticals International, plc | Director | Class A Ordinary Share | 12.5K | $321K | $25.60 | Jun 5, 2025 | Direct |
| Kiniksa Pharmaceuticals, Ltd. | Director | Class A Common Share | 9.37K | $168K | $17.88 | Jun 6, 2024 | Direct |
| CASTLE BIOSCIENCES INC | Director | Restricted Stock Units | 13.7K | $0 | $24.95 | May 22, 2025 | Direct |
| Kiniksa Pharmaceuticals International, plc | Director | Share Option | 16.8K | Jun 3, 2025 | Direct | ||
| Kiniksa Pharmaceuticals International, plc | Director | Restricted Share Units | 0 | Jun 5, 2025 | Direct | ||
| Kiniksa Pharmaceuticals, Ltd. | Director | Restricted Share Units | 0 | Jun 6, 2024 | Direct |